| Title |
Development and Validation of the Revised Patients’ Attitudes Towards Deprescribing (rPATD) Questionnaire: Versions for Older Adults and Caregivers
|
|---|---|
| Published in |
Drugs & Aging, October 2016
|
| DOI | 10.1007/s40266-016-0410-1 |
| Pubmed ID | |
| Authors |
Emily Reeve, Lee-Fay Low, Sepehr Shakib, Sarah N. Hilmer |
| Abstract |
Knowledge of consumer (patient and caregiver) attitudes is essential for conducting medication optimization in practice. The aim of this study was to develop and validate a questionnaire to capture older adults' and caregivers' beliefs and attitudes towards deprescribing. The previously validated Patients' Attitudes Towards Deprescribing (PATD) questionnaire was expanded based on literature review, expert opinion and focus groups, and a caregivers' version was developed. The revised questionnaire was piloted and then distributed for self-completion to older adults (≥65 years of age), taking at least one regular medication and caregivers of older adults. Psychometric validity and reliability were examined. Responses to questions that were identified to group into a specific factor were combined to produce a score. A total of 383 consumer questionnaires and 200 caregiver questionnaires were completed and included in analysis. Exploratory factor analysis revealed four factors in both versions of the questionnaire (with four to five questions retained in each factor). The factors relate to the perceived burden of medication taking, belief in appropriateness of medication use (harms and benefits), concerns about stopping the medication, and level of involvement/knowledge of medications. Internal consistency of all factors was acceptable with Cronbach's alpha >0.6. In both the older adults' and caregivers' versions, the burden score was inversely associated with the appropriateness score (p < 0.001 both versions). Factor scores between administration times (test-retest reliability) were statistically significantly correlated (p = 0.000), with gamma values ranging between 0.57 and 0.89. The revised PATD questionnaire had acceptable validity and reliability. This newly validated questionnaire may provide insight into individuals' willingness for/barriers to deprescribing, with applications in practice and research. |
X Demographics
The data shown below were collected from the profiles of 38 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 9 | 24% |
| Spain | 7 | 18% |
| Canada | 4 | 11% |
| United States | 2 | 5% |
| Chile | 1 | 3% |
| United Kingdom | 1 | 3% |
| Grenada | 1 | 3% |
| Colombia | 1 | 3% |
| Unknown | 12 | 32% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 18 | 47% |
| Practitioners (doctors, other healthcare professionals) | 9 | 24% |
| Scientists | 8 | 21% |
| Science communicators (journalists, bloggers, editors) | 3 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 123 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 123 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 23 | 19% |
| Student > Master | 19 | 15% |
| Researcher | 17 | 14% |
| Student > Doctoral Student | 10 | 8% |
| Student > Bachelor | 8 | 7% |
| Other | 24 | 20% |
| Unknown | 22 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 39 | 32% |
| Pharmacology, Toxicology and Pharmaceutical Science | 26 | 21% |
| Nursing and Health Professions | 13 | 11% |
| Social Sciences | 6 | 5% |
| Agricultural and Biological Sciences | 4 | 3% |
| Other | 9 | 7% |
| Unknown | 26 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2018.
All research outputs
#1,405,002
of 22,896,955 outputs
Outputs from Drugs & Aging
#56
of 1,201 outputs
Outputs of similar age
#27,651
of 314,207 outputs
Outputs of similar age from Drugs & Aging
#2
of 20 outputs
Altmetric has tracked 22,896,955 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,201 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 314,207 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.